Mechanisms of action and synergies of a novel lipid IVA biosynthesis inhibitor
Emma R. HoldeniD, Muhammad YasiriD, A. Keith TurneriD, Mark Alexander WebberiD, Ian G. CharlesiD, Ed Siegwart, Tony M. RaynhamiD, Ajay MistryiD, John GeorgeiD, Matthew W. GilmouriD
Abstract
The development of novel antimicrobials provides additional treatment options for infectious diseases, including antimicrobial resistant infections. There are many hurdles to antimicrobial development and identifying an antimicrobials mechanism of action is a crucial step in progressing candidate molecules through the drug discovery pipeline. We used the genome wide screening method TraDIS-Xpress to identify genes in two model Gram-negative bacteria that affected sensitivity to three analogues of a novel antimicrobial compound (OPT-2U1). TraDIS-Xpress identified that all three analogues targeted the lipid IVA biosynthetic pathway in E. coli and Salmonella Typhimurium. Specifically, we determined that the antimicrobial target was likely to be LpxD, and validated this by finding a 5 log2-fold increase in the MIC of the OPT-2U1 analogues in E. coli when lpxD was overexpressed. Synergies were identified between OPT-2U1 analogues combined with rifampicin or colistin, to varying strengths, in both E. coli and S. Typhimurium. LPS composition was a likely reason for differences between E. coli and S.Typhimurium, as perturbation of LPS synthesis affected synergy between antibiotics and OPT-2U1 analogues. Finally, genes involved in ATP synthesis and membrane signalling functions were also found to affect the synergy between colistin and OPT-2U1 analogues. TraDIS-Xpress has proven a powerful tool to rapidly assay all genes (and notably, essential genes) within a bacterium for roles in dictating antimicrobial sensitivity. This study has confirmed the predicted target pathway of OPT-2U1 and identified synergies which could be investigated for development of novel antimicrobial formulations. Data SummaryNucleotide sequence data supporting the analysis in this study has been deposited in ArrayExpress under the accession number E-MTAB-13250. The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Two distinct mechanisms of small molecule inhibition of LpxA acyltransferase essential for lipopolysaccharide biosynthesis
- Antibiotic-induced accumulation of lipid II sensitizes bacteria to antimicrobial fatty acids
A. E. Sidders, K. M. Kedziora, … B. P. Conlon·bioRxiv·May 3, 2022
- Same same but different; The global response of Escherichia coli to five different LpxC inhibitors
A. M. Moller, M. Vazquez Hernandez, … F. Narberhaus·bioRxiv·Jul 25, 2023
- The Testing and Characterization of the Bacterial Response to Novel Lipid Ether Amine-Based Antibiotics
Daniel J. Gibson, Artem S. Svetlov·bioRxiv·Jul 23, 2026
- Novel inhibitors of E. coli lipoprotein diacylglyceryl transferase are insensitive to resistance caused by lpp deletion
J. Diao, R. Komura, … S. B. Kapadia·bioRxiv·Oct 4, 2020
- A novel broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance
Wenyan He, Xueting Huan, … Zongqiang Wang·Nature CommunicationsPeer-reviewed·Jul 31, 2025